近年来，关于癌症相关血栓形成的知识有了很大发展。实用指南是在法语呼吸系统疾病协会 (SPLF) 领导的 INNOVTE FCRIN 网络的倡议下起草的，由一个协调小组、一个写作小组和一个审查小组，由在不同环境下实践的不同科学协会参与。该方法遵循法国国家卫生局（HAS）的《临床实践指南》流程。经过文献查阅，制定、完善指南，然后由工作组验证。这些指南根据现有临床试验和观察性研究的数据，讨论了疾病和管理的多个方面：流行病学、初始治疗、治疗持续时间、延长治疗、复发性血栓形成、中心静脉导管血栓形成、偶发性血栓形成、血小板减少症的治疗。基于证据的指南旨在指导癌症相关血栓形成患者的实际管理。版权所有 © 2023 作者。由 Elsevier Masson SAS 出版。保留所有权利。

In recent years, knowledge about cancer associated thrombosis has evolved considerably.Practical guidelines were drafted on the initiative of the INNOVTE FCRIN Network, led by the French Speaking Society of Respiratory Diseases (SPLF), by a coordinating group, a writing group, and a review group, with the involvement of different scientific societies practicing in various settings. The method followed the "Clinical Practice Guidelines" process of the French National Authority for Health (HAS).After a literature review, guidelines were formulated, improved, and then validated by the working groups. These guidelines addressed multiple aspects of the disease and management from the data of available clinical trials and observational studies : epidemiology, initial treatment, treatment duration, extended treatment, recurrent thrombosis, central venous catheter thrombosis, incidental thrombosis, treatment in case of thrombocytopenia.These evidence-based guidelines are intended to guide the practical management of patients with cancer associated thrombosis.Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.